These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11291612)

  • 1. [Hypertrophy, rebuilding and remodeling of myocardium. Causes, clinical significance and therapeutic implications].
    Irzmański R; Pawlicki L
    Pol Arch Med Wewn; 2000; 103(5-6):295-9. PubMed ID: 11291612
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical remodeling in left ventricular hypertrophy-is there a unifying hypothesis for the variety of electrocardiographic criteria for the diagnosis of left ventricular hypertrophy?
    Rodriguez-Padial L; Bacharova L
    J Electrocardiol; 2012 Sep; 45(5):494-7. PubMed ID: 22809575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular hypertrophy - current views on the pathophysiology, association with cardiovascular risk, and therapeutic options].
    Rostoff P; Gackowski A; Nessler J; Piwowarska W
    Kardiol Pol; 2010 Jul; 68(7):815-23. PubMed ID: 20648446
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications.
    Aro AL; Chugh SS
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003629. PubMed ID: 27009417
    [No Abstract]   [Full Text] [Related]  

  • 5. The structural and electrical remodeling of myocardium in LVH and its impact on the QRS voltage.
    Bacharova L
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():37-42. PubMed ID: 17584677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of left ventricular hypertrophy and implications for regression.
    Artham SM; Lavie CJ; Milani RV; Patel DA; Verma A; Ventura HO
    Prog Cardiovasc Dis; 2009; 52(2):153-67. PubMed ID: 19732607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists].
    González-Juanatey JR; Vallés Belsué F
    Med Clin (Barc); 2000; 114 Suppl 1():39-42. PubMed ID: 10812574
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiopathology of left ventricular hypertrophy].
    Waeber B; Weber R; Brunner HR
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():9-14. PubMed ID: 7646313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geometric patterns of left ventricular hypertrophy and electrocardiography.
    Costa Fde A; Bombig MT; de Lima VC; de Souza D; Luna Filho B; Fonseca FH; Izar MC; da Costa W; Riera AR; Póvoa R
    Int J Cardiol; 2011 Sep; 151(3):374-5. PubMed ID: 21764471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysiological cellular changes induced by the hypertrophy in ventricular myocytes of the rats stimulated at a different frequency].
    Cacciani F; Zaniboni M; Stilli D; Sgoifo A; Berni R; Macchi E; Musso E
    Acta Biomed Ateneo Parmense; 2001; 72(1-2):19-24. PubMed ID: 11554120
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
    Phillips RA; Diamond JA; Gharavi A
    Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
    [No Abstract]   [Full Text] [Related]  

  • 14. LVH: consequences associated with cardiac remodeling.
    Titcomb CP
    J Insur Med; 2004; 36(1):42-6. PubMed ID: 15104028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECG manifestations of left ventricular electrical remodeling.
    Estes EH
    J Electrocardiol; 2012; 45(6):612-6. PubMed ID: 23022308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
    Mansoor GA; Massie BM
    Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats.
    Toh R; Kawashima S; Kawai M; Sakoda T; Ueyama T; Satomi-Kobayashi S; Hirayama S; Yokoyama M
    J Am Coll Cardiol; 2004 Jun; 43(12):2337-47. PubMed ID: 15193703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparative characteristics of left ventricular myocardium remodeling in arterial hypertension of different genesis].
    Potekhin NP; Serebrianskiĭ IuE; Orlov FA
    Voen Med Zh; 2004 Jun; 325(6):32-6. PubMed ID: 15327138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Chrysanthemum indicum on ventricular remodeling in rats].
    Wu Q; Chen CX; Gu WL; Gao JP; Wan Y; Lv J
    Zhong Yao Cai; 2010 Jul; 33(7):1112-5. PubMed ID: 21137368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of regression of left ventricular hypertrophy following alcohol ablation of the interventricular septum in patients with hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.
    Dąbrowski M; Chojnowska L; Małek L; Spiewak M; Kuśmierczyk B; Koziarek J; Klisiewicz A; Miśko J; Witkowski A
    Kardiol Pol; 2012; 70(8):782-8. PubMed ID: 22933209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.